Affiliated with RC | false |
Status | 已發表Published |
Opportunities and Challenges of Multinational Pharmaceutical Enterprises in Transforming Pharmaceutical Market in China | |
Linfeng Hu1; Zhong Yu2; Qingwen Yuan3; Yuanjia Hu3![]() ![]() | |
2019-03 | |
Source Publication | Therapeutic innovation & regulatory science
![]() |
ISSN | 2168-4790 |
Volume | 53Issue:2Pages:207-214 |
Abstract | The surging costs of health care in China is highly related to the high expenses in pharmaceutical costs. Since the Government of China launched the health care reform in 2009, the issue of growing pharmaceutical expenditure continues to grasp policy makers’ attention. Since 2015, an ongoing series of drug-related policies have been revised or developed, resulting in profound impact on the overall pharmaceutical market in China, and the dynamic is still evolving. As China has become the second largest pharmaceutical market in the world, any volatility in the Chinese pharmaceutical market may have great implications to multinational pharmaceutical markets that have had their products launched in China or plan to extend their business to the Chinese market. Based on a comprehensive analysis of the most recent health care reform policies in China, the objectives of this study were to identify the major opportunities appealed to and the challenges confronted by multinational pharmaceutical enterprises in the current Chinese pharmaceutical market. |
Keyword | China Health Care Reform Multinational Pharmaceutical Enterprises Pharmaceutical Market |
DOI | 10.1177/2168479018772820 |
Indexed By | SCIE |
WOS Research Area | Medical Informatics ; Pharmacology & Pharmacy |
WOS Subject | Medical Informatics ; Pharmacology & Pharmacy |
WOS ID | WOS:000462049200008 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | University of Macau |
Corresponding Author | Carolina Oi Lam Ung |
Affiliation | 1.Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, Chongqing, China 2.Chongqing Huapont Pharmaceutical Co, Ltd, Chongqing, China 3.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China |
Corresponding Author Affilication | Institute of Chinese Medical Sciences |
Recommended Citation GB/T 7714 | Linfeng Hu,Zhong Yu,Qingwen Yuan,et al. Opportunities and Challenges of Multinational Pharmaceutical Enterprises in Transforming Pharmaceutical Market in China[J]. Therapeutic innovation & regulatory science,2019,53(2):207-214. |
APA | Linfeng Hu,Zhong Yu,Qingwen Yuan,Yuanjia Hu,&Carolina Oi Lam Ung.(2019).Opportunities and Challenges of Multinational Pharmaceutical Enterprises in Transforming Pharmaceutical Market in China.Therapeutic innovation & regulatory science,53(2),207-214. |
MLA | Linfeng Hu,et al."Opportunities and Challenges of Multinational Pharmaceutical Enterprises in Transforming Pharmaceutical Market in China".Therapeutic innovation & regulatory science 53.2(2019):207-214. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment